1. Liu, Yan, He, Enping, Zhang, Yanling, Zeng, Youqing, Leng, Ping. . WW domain binding protein 2 (WBP2) as an oncogene in breast cancer: mechanisms and therapeutic prospects-a narrative review. In Gland surgery, 11, 1984-2002. doi:10.21037/gs-22-716. https://pubmed.ncbi.nlm.nih.gov/36654949/
2. Chen, Shuai, Wang, Han, Huang, Yu-Fan, Tzeng, Chi-Meng, Zhang, Zhi-Ming. 2017. WW domain-binding protein 2: an adaptor protein closely linked to the development of breast cancer. In Molecular cancer, 16, 128. doi:10.1186/s12943-017-0693-9. https://pubmed.ncbi.nlm.nih.gov/28724435/
3. Chen, Shuai, Wang, Han, Li, Zhi, Tzeng, Chi-Meng, Zhang, Zhi-Ming. 2018. Interaction of WBP2 with ERα increases doxorubicin resistance of breast cancer cells by modulating MDR1 transcription. In British journal of cancer, 119, 182-192. doi:10.1038/s41416-018-0119-5. https://pubmed.ncbi.nlm.nih.gov/29937544/
4. Kang, Shin-Ae, Guan, Jye Swei, Tan, Hock Jin, Lee, Soo Chin, Lim, Yoon Pin. 2018. Elevated WBP2 Expression in HER2-positive Breast Cancers Correlates with Sensitivity to Trastuzumab-based Neoadjuvant Therapy: A Retrospective and Multicentric Study. In Clinical cancer research : an official journal of the American Association for Cancer Research, 25, 2588-2600. doi:10.1158/1078-0432.CCR-18-3228. https://pubmed.ncbi.nlm.nih.gov/30593516/
5. Hum, Melissa, Tan, Hock Jin, Yang, Yixuan, Teh, Ming, Lim, Yoon Pin. . WBP2 promotes gastric cancer cell migration via novel targeting of LATS2 kinase in the Hippo tumor suppressor pathway. In FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 35, e21290. doi:10.1096/fj.202000393R. https://pubmed.ncbi.nlm.nih.gov/33475198/
6. Zheng, Zhe, Li, Yue, Fan, Siyuan, Zhu, Feng, Huang, Kai. 2021. WW domain-binding protein 2 overexpression prevents diet-induced liver steatosis and insulin resistance through AMPKβ1. In Cell death & disease, 12, 228. doi:10.1038/s41419-021-03536-8. https://pubmed.ncbi.nlm.nih.gov/33658485/
智鼠故事 
